Filter By
Only Dataset Has Survey
Maps
Vendors
Collection Dates
File Formats
Search
Data Projects
518 Results
Sort By
Recommended
Data Owner:
Environics Research
Region:Argentina, Brazil, United Kingdom, Canada, Chile, China, France, Germany, India, Indonesia, Italy, Japan, Korea, Republic of, Nigeria, Russia, Spain, Sweden, Turkey
Collection Date:2001 Oct 01
Topic:Social Sciences
Environics Corporate Social Responsibility Monitor 2002 is a survey of global public opinion on the role of companies in society. This survey is based on the the results of face-to-face or telephone surveys with representative samples of about 1,000 citizens in each of 25 countries on six continents at varying stages of development. Research was carried out by respected social research institutes in each country between October and December 2001.
Data Owner:
The Université du Québec à Montréal (UQAM)
The 2015 Canadian Election Study consists of 4 waves. Note that each survey wave is a different questionnaire: CPS is the Campaign Period Survey (by telephone), PES is the Post-Election Survey (by telephone), MBS is the Mailback Survey, and WEB is the final Web-based survey.
Data Owner:
Western University
This election study survey is based upon questions asked in the Canadian Election Study, but tailored for the Newfoundland and Labrador context. It was conducted by the Consortium on Electoral Democracy (C-Dem).
Data Owner:
IranPoll
IranPoll is an opinion research and polling company headquartered in Canada, where local knowledge, scientific approach, and practical experience intersect to produce evidence-based insight at competitive prices. As the subdivision of VoxNations that focuses exclusively on Iran, IranPoll provides its clients with tailored opinion research services and a dispassionate understanding of the Iranian people.
Data Owner:
Environics Research
Region:Argentina, Brazil, United Kingdom, Canada, Chile, China, France, Germany, India, Indonesia, Italy, Japan, Korea, Republic of, Nigeria, Russia, Spain, Sweden, Turkey
Collection Date:2000 Nov 23
Topic:Social Sciences
The findings of the Environics Global Issues Monitor, 2001 Survey are based on the results of face-to face or telephone interviews with representative samples of about 1,000 citizens in each of 20 countries on five continents. Environics 2001 Global Issues Monitor survey was conducted in the following countries: Argentina, Brazil, Canada, Chile, China, France, Germany, Great Britain, India, Indonesia, Italy, Japan, Mexico, Nigeria, Russia, South Korea, Spain, Sweden, Turkey, United States. Research was conducted by respected social research institutes in each country between November 23, 2000 and February 9, 2001. In Canada, the survey was conducted by Environics Research Group Ltd. It consisted of a nation-wide telephone survey with a sample of 1,015 individuals, 18 years and older carried out between December 11 and December 19, 2000.
Data Owner:
Environics Research
Almost no public opinion research has been conducted to date on the general topic of contaminated sites at a national level. The purpose of this research is to measure Canadian public opinion on the issue of contaminated sites to provide a baseline from which future studies can be conducted to measure changes in opinions in response to government communications initiatives.
Data Owner:
Environics Research
Region:Argentina, Brazil, United Kingdom, Canada, Chile, China, France, Germany, India, Indonesia, Italy, Japan, Korea, Republic of, Nigeria, Russia, Spain, Sweden, Turkey
Collection Date:2001 Oct 08
Topic:Social Sciences
Environics Corporate Social Responsibility Monitor 2002 is a survey of global public opinion on the role of companies in society. This survey is based on the the results of face-to-face or telephone surveys with representative samples of about 1,000 citizens in each of 25 countries on six continents at varying stages of development. The survey was fielded after September 11 in each country. Media focus on the Enron Corp. did not begin until the survey was completed in the USA.
Despite global progress in childhood vaccination coverage, fragile and humanitarian countries, with high burden of infectious diseases, continue to report a significant number of zero-dose and under-vaccinated children. Efforts to equitably reach zero-dose children remain thus critical. This study assesses the prevalence and determinants of zero-dose children in fragile context of Somalia. We used secondary data from 2020 Somali Health and Demographic Survey (SHDS) to determine status of unvaccinated children aged between 12 to 23 months. Variables related to socio-demographic, household, health seeking, and community level factors were extracted from the SHDS data. Variables that were shown to be significantly associated with zero-dose children at p< 0.05 in the single logistic regression analysis were identified and included in a final multiple logistic regression analysis. A total of 2,304 women and their children aged between 12–23 months were used to determine the prevalence and determinants of zero dose children in Somalia. Approximately 60.2% of the children were zero dose children and did not receive any dose of the four basic routine vaccines. Children living in rural and nomadic areas were more likely to be zero dose (aOR 1.515, 95% CI: 1.189–1.93). Mother with primary education and above (aOR 0.519, 95% CI: 0.371–0.725), those who attended antenatal care (aOR 0.161, 95% CI: 0.124–0.209) and postnatal care (aOR 0.145, 95% CI: 0.085–0.245) and listen frequently to radio (aOR 2.212, 95% CI: 1.106–4.424) were less likely to have children with zero dose than with their counterparts. Majority of children under two years of age in Somalia are reported to be zero dose children. Context and population specific interventions that target vulnerable mothers and their children, in rural and nomadic areas, and from lower wealth quintile index families with no education and adequate access to antenatal and postnatal care remain critical.
Extrapulmonary Tuberculosis (EPTB) poses challenges from patient and health system perspectives. The cost-effectiveness analysis of the Xpert MTB/RIF (Xpert) test to diagnose pulmonary tuberculosis is documented. However, there are no economic evaluations for EPTB. Considering the reported better diagnostic sensitivity of the MPT64 test, this study explored its cost-effectiveness as an alternative diagnostic test. We conducted this economic evaluation to assess the cost-effectiveness of the MPT64 test compared to Xpert and ZN microscopy for EPTB adult patients. We utilised a Markov modelling approach to capture short- and long-term costs and benefits from a health system perspective. For the model inputs, we combined data from our cohort studies in Tanzania and peer-reviewed EPTB literature. We calculated the Incremental Cost Effectiveness Ratio (ICER) by comparing the cost (in USD) of each diagnostic test and Quality Adjusted Life Years (QALYs) as health gain. We found the MPT64 test cost-effective for EPTB diagnosis and absolutely dominated ZN microscopy and Xpert using the baseline model inputs. A scenario analysis showed that the Xpert test might be the most cost-effective at its higher test sensitivity, which corresponds to using it to diagnose lymph node aspirates. The prevalence of HIV among EPTB cases, their probability of treatment, costs of ART, and the probability of the MPT64 test in detecting EPTB patients were the main parameters associated with the highest impact on ICER in one-way deterministic analysis. The most cost-effective option for EPTB at the baseline parameters was the MPT64 diagnostic test. Including the MPT64 test in EPTB diagnostic pathways for previously untreated patients can lead to better resource use. The Xpert test was the most cost-effective diagnostic intervention at a higher diagnostic test sensitivity in scenario analyses based on different sites of infection, such as for the lymph node aspirates.
Extrapulmonary Tuberculosis (EPTB) poses challenges from patient and health system perspectives. The cost-effectiveness analysis of the Xpert MTB/RIF (Xpert) test to diagnose pulmonary tuberculosis is documented. However, there are no economic evaluations for EPTB. Considering the reported better diagnostic sensitivity of the MPT64 test, this study explored its cost-effectiveness as an alternative diagnostic test. We conducted this economic evaluation to assess the cost-effectiveness of the MPT64 test compared to Xpert and ZN microscopy for EPTB adult patients. We utilised a Markov modelling approach to capture short- and long-term costs and benefits from a health system perspective. For the model inputs, we combined data from our cohort studies in Tanzania and peer-reviewed EPTB literature. We calculated the Incremental Cost Effectiveness Ratio (ICER) by comparing the cost (in USD) of each diagnostic test and Quality Adjusted Life Years (QALYs) as health gain. We found the MPT64 test cost-effective for EPTB diagnosis and absolutely dominated ZN microscopy and Xpert using the baseline model inputs. A scenario analysis showed that the Xpert test might be the most cost-effective at its higher test sensitivity, which corresponds to using it to diagnose lymph node aspirates. The prevalence of HIV among EPTB cases, their probability of treatment, costs of ART, and the probability of the MPT64 test in detecting EPTB patients were the main parameters associated with the highest impact on ICER in one-way deterministic analysis. The most cost-effective option for EPTB at the baseline parameters was the MPT64 diagnostic test. Including the MPT64 test in EPTB diagnostic pathways for previously untreated patients can lead to better resource use. The Xpert test was the most cost-effective diagnostic intervention at a higher diagnostic test sensitivity in scenario analyses based on different sites of infection, such as for the lymph node aspirates.